Brain-computer Interface

2

Review clinical trials related to Brain-computer Interface. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System

This research study is being done to develop a novel brain-computer interface (BCI) technology that can enable severely paralyzed individuals to interact with the world through direct brain-control of a computer. This technology is named MindEx (for Mind Extender). It utilizes four implanted "chips" in the human brain from which investigators can record brain activity during subjects' thoughts and decode meaningful information from this activity to be used as control signals for a computer, a laptop, or a tablet. The use of four brain regions is a significant differentiating feature and scientific innovation of this study over much prior work in this space, that typically derived control signals from one, or sometimes two brain regions. The brain regions to be used here can allow the decode of multiple variables simultaneously, including not just moment-to-moment position, but also high-level goals, intentions, decisions, scene comprehension, and error-related signals involved in natural human behavior. The research is being done through a prospective, longitudinal, single-arm early feasibility study to examine the safety and effectiveness of using MindEx to provide the user an intuitive, efficient, and accurate ability to control multiple applications on a computer interface such as a word processor, a paint application, or to play simple video games. Such versatility could greatly improve the autonomy and quality of life of severely paralyzed individuals. Two subjects will be enrolled, each implanted with MindEx for a period of at least 53 weeks and up to 313 weeks. The study is expected to take at least one year and up to six years in total.

Participants needed: 2
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Nader PouratianUpdated: Oct 1, 2026Locations: 1
Eligibility criteria

Paralysis resulting from cervical spinal cord injury (SCI), brainstem stroke (is... [+9]

Presence of memory problems [+21]

Status: Not yet recruiting

Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke Survivors

This study focuses on monitoring real-world customers who have been prescribed the IpsiHand® as part of their rehabilitation post-stroke. This study aims to evaluate their progress over time, assessing motor recovery, functional independence in activities of daily living (ADLs), caregiver burden, and health economic outcomes.

Participants needed: 100
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: Neurolutions, Inc.Updated: Aug 29, 2025Duration: 2 Years
Eligibility criteria

Adult age 18-85 years. [+2]

Severe cognitive impairment that would impede utilization of IpsiHand® [+2]